* DISCLAIMER: All information including our "Interest Level" rating, is provided merely for informational purposes. ICO Drops does not provide investment advice (read more).
Important: No ICO
Atlas Logo

Atlas Protocol

(Advertising)
An open protocol directly connecting advertisers, publishers, and users in token-based digital marketing.
Token Sale ended
25 October 2018
$30,000,000
OF
$30,000,000 (100%)
WEBSITE
WHITEPAPER

Market & Returns

    ATP token price
  • $0.0038 (-2.14%)
  • 0.00002312 ETH
  • 0.00000045 BTC
24h Volume
$154,144
Market Cap
$9,702,597
    Returns since ICO
  • 0.38x
    USD
  • 0.47x
    ETH
  • 0.29x
    BTC
  • These numbers show how much the token price has changed relative to the initial ICO token price.

    Token Sale: until 25 Oct

  • Ticker: ATP
  • Token type: NRC20
  • ICO Token Price: 1 ATP = 0.01000 USD
  • Fundraising Goal: 30,000,000 USD
  • Total Tokens: 10,000,000,000
  • Available for Token Sale: 40%
  • Short Review

  • Role of Token: Utility
  • Additional links

    Screenshots

    Atlas Protocol Features Overview
    Atlas Protocol Features Overview
    Atlas Protocol Roadmap
    Atlas Protocol Roadmap
    Atlas Protocol Team
    Atlas Protocol Team
    Atlas Protocol Advisors 1
    Atlas Protocol Advisors 1
    Atlas Protocol Advisers 2
    Atlas Protocol Advisers 2
    Atlas Protocol Investors And Partners
    Atlas Protocol Investors And Partners

    DAOstack

    Blockchain Service
    $30,000,000 / $30,000,000 100%
    DAOstack is designed to catalyze...
    Medium
    Blockchain Service
    $30,000,000 100%
    $30,000,000
    Ended: 8 May

    Orchid Protocol

    Blockchain Service
    $40,800,000 RECEIVED
    The Orchid Protocol is the...
    Not Rated
    Blockchain Service
    $40,800,000
    Not Set
    Ended

    CRYPTO20

    CryptoFund
    $37,700,000 / $75,000,000 50%
    The First Tokenized Cryptocurrency...
    Neutral
    CryptoFund
    $37,698,373 50%
    $75,000,000
    Ended: 1 Dec

    Lympo

    Healthcare
    $16,860,000 / $12,680,000 133%
    Lympo aspires to revolutionise...
    Not Rated
    Healthcare
    $16,857,899 133%
    $12,680,000
    Ended: 28 Feb